- Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
May 15, 2026 · gurufocus.com
Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Ne
- Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
May 15, 2026 · prnewswire.com
BENSALEM, Pa., May 15, 2026 /PRNewswire/ -- The Law Offices of Howard G.
- REGENCELL BIOSCIENCE HOLDINGS LIMITED (RGC) SHAREHOLDERS WHO LOST MONEY HAVE OPPORTUNITY TO LEAD SECURITIES FRAUD LAWSUIT
May 15, 2026
BENSALEM, PA., MAY 15, 2026 /PRNEWSWIRE/ -- THE LAW OFFICES OF HOWARD G.
- RGC UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Deadline on June 23, 2026
May 15, 2026 · gurufocus.com
RGC UPCOMING DEADLINE: Faruqi and Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Deadline on June 23, 2026
- RGC UPCOMING DEADLINE : The Gross Law Firm Alerts Regencell Bioscience Holdings Limited Stockholders of Securities Class Action - Contact the Firm
May 15, 2026 · globenewswire.com
NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Regencell Bioscience Holdings Limited (NASDAQ: RGC). Shareholders who purchased shares of RGC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- RGC UPCOMING DEADLINE : THE GROSS LAW FIRM ALERTS REGENCELL BIOSCIENCE HOLDINGS LIMITED STOCKHOLDERS OF SECURITIES CLASS ACTION - CONTACT THE FIRM
May 15, 2026
NEW YORK, MAY 15, 2026 (GLOBE NEWSWIRE) -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHAREHOLDERS OF REGENCELL BIOSCIENCE HOLDINGS LIMITED (NASDAQ: RGC). SHAREHOLDERS WHO PURCHASED SHARES OF RGC DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENT.
- RGC UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Deadline on June 23, 2026
May 15, 2026 · prnewswire.com
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Regencell To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Regencell between October 28, 2024 and October 31, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, May 15, 2026 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Regencell Bioscience Holdings Limited ("Regencell" or the "Company") (NASDAQ: RGC) and reminds investors of the June 23, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- RGC UPCOMING DEADLINE: FARUQI & FARUQI, LLP REMINDS REGENCELL BIOSCIENCE (RGC) INVESTORS OF SECURITIES CLASS ACTION DEADLINE ON JUNE 23, 2026
May 15, 2026
FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES IN REGENCELL TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS IF YOU PURCHASED OR ACQUIRED SECURITIES IN REGENCELL BETWEEN OCTOBER 28, 2024 AND OCTOBER 31, 2025 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT. 1310). [YOU MAY ALSO CLICK HERE FOR ADDITIONAL INFORMATION] NEW YORK, MAY 15, 2026 /PRNEWSWIRE/ -- FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST REGENCELL BIOSCIENCE HOLDINGS LIMITED ("REGENCELL" OR THE "COMPANY") (NASDAQ: RGC) AND REMINDS INVESTORS OF THE JUNE 23, 2026 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY.
- Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers - RGC
May 14, 2026 · prnewswire.com
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Regencell Bioscience Holdings Limited ("Regencell" or the "Company") (NASDAQ: RGC) and certain officers. The class action, filed in the United States District Court for the District of Maryland, and docketed under 26-cv-01602, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Regencell securities between October 28, 2024 and October 31, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- POMERANTZ LAW FIRM ANNOUNCES THE FILING OF A CLASS ACTION AGAINST REGENCELL BIOSCIENCE HOLDINGS LIMITED AND CERTAIN OFFICERS - RGC
May 14, 2026
NEW YORK, MAY 14, 2026 /PRNEWSWIRE/ -- POMERANTZ LLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST REGENCELL BIOSCIENCE HOLDINGS LIMITED ("REGENCELL" OR THE "COMPANY") (NASDAQ: RGC) AND CERTAIN OFFICERS. THE CLASS ACTION, FILED IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND, AND DOCKETED UNDER 26-CV-01602, IS ON BEHALF OF A CLASS CONSISTING OF ALL PERSONS AND ENTITIES OTHER THAN DEFENDANTS THAT PURCHASED OR OTHERWISE ACQUIRED REGENCELL SECURITIES BETWEEN OCTOBER 28, 2024 AND OCTOBER 31, 2025, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), SEEKING TO RECOVER DAMAGES CAUSED BY DEFENDANTS' VIOLATIONS OF THE FEDERAL SECURITIES LAWS AND TO PURSUE REMEDIES UNDER SECTIONS 10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER, AGAINST THE COMPANY AND CERTAIN OF ITS TOP OFFICIALS.
